002100.SZ
天康生物
SZSE · Consumer Defensive · C 制造业 · CN
CNY 7.17
+0.28%Aug 28, 2026, 11:35 UTC
Tiankang Biopharmaceutical announced the termination of a non-public offering fundraising project for a pig breeding and fattening base, with remaining funds to be permanently used as working capital.
Source:Aug 26, 2026, 11:06 UTC
Tiankang Biological reported a net loss of 441 million yuan for the first half of 2026, turning from a profit of 338 million yuan in the same period of 2025.
Source:Aug 7, 2026, 10:38 UTC
Tiankang Biotech announced July 2026 hog sales of 396,100 heads, up 27.45% year-on-year, with sales revenue of 393 million yuan, down 12.47% year-on-year.
Source: